Historique
Article de Périodique
Recognition and management of complications of new recreationnal drug use (2005)
(Reconnaissance et prise en charge des complications liées aux nouvelles drogues récréatives)
Auteur(s) :
RICAURTE, G. A. ;
McCANN, U. D.
Année
2005
Page(s) :
2137-2145
Langue(s) :
Anglais
Refs biblio. :
55
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
DROGUES DE SYNTHESE
;
EFFET SECONDAIRE
;
PATHOLOGIE ORGANIQUE
;
TOXICITE
;
DIAGNOSTIC
;
TRAITEMENT
;
MILIEU FESTIF
;
USAGE RECREATIF
;
BRONCHODILATATEURS
;
GHB
;
BENZODIAZEPINES
;
KETAMINE
;
MDMA-ECSTASY
Note générale :
Commentaries:
- Debating drug use openly, p. 2064.
- GHB - sense and sociability, p. 2146.
- Debating drug use openly, p. 2064.
- GHB - sense and sociability, p. 2146.
Résumé :
Use of illicit drugs in clubs and large dance parties (so-called raves) is a burgeoning cultural trend. Such recreational drug use is associated with several medical complications, both acute and longlasting. Although few, if any, of the drugs currently used in recreational venues are truly new, their patterns and context of use have changed (a great deal in some instances). For some of these substances, this cultural repackaging of the drug experience has resulted in various medical disorders that have previously gone undocumented. This review aims to help treating physicians recognise and manage complications associated with the use of new drugs in clubs, including methylenedioxymethamfetamine, ephedrine, g-hydroxybutyrate; g-butyrolactone, 1,4-butanediol, flunitrazepam, ketamine, and nitrites. We also alert researchers to specific toxic effects of club-drugs on which more basic information is needed.
Affiliation :
Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD, USA